The Prelieve Trial - Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients

NACompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

October 11, 2017

Primary Completion Date

May 1, 2021

Study Completion Date

March 2, 2022

Conditions
Heart Failure Low OutputHeart Failure
Interventions
DEVICE

Occlutech AFR device

Catheter-guided placement of an AFR device following balloon atrial septostomy.

Trial Locations (26)

1090

University Hospital Brussels, Brussels

3000

UZ Leuven, Leuven

9000

AZ Maria Middelares, Ghent

9300

Algemeen Stedelijk Ziekenhuis (Asz), Aalst

OLV (Onze-Lieve-Vrouwziekenhuis) Hospital Aalst, Aalst

34452

İstanbul Üniversitesi, Istanbul

34865

Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi, Istanbul

35020

Tepecik Eğitim Ve Araştırma Hastanesi, Izmir

35620

İzmir Kâtip Çelebi Üniversitesi, Izmir

58140

Sivas Cumhuriyet Üniversitesi Tıp Fakültesi Araştırma ve Uygulama Hastanesi, Sivas

Unknown

Charité - Universitätsmedizin Berlin, Berlin

Vivantes Klinikum im Friedrichshain, Berlin

Herzzentrum Uniklinik Köln, Cologne

CardioVasculäres Centrum Frankfurt, Frankfurt

Cardiologicum Hamburg, Hamburg

Medizinische Hochschule Hannover, Hanover

University of Homburg, Homburg

Herzzentrum Leipzig, Leipzig

Uniklinikum Magdeburg A. ö. R., Magdeburg

Universitätsmedizin Rostock, Rostock

University of Würzburg, Würzburg

Ege Üniversitesi Hastanesi, Izmir

Bezmialem University, Istanbul

Kocaeli Üniversitesi Hastanesi, Kocaeli

06110

Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, Ankara

06230

Hacettepe Üni Hastanesi, Ankara

Sponsors
All Listed Sponsors
lead

Occlutech International AB

INDUSTRY